ArticleJournal of neurology2026
Pregnancy in women with spinal muscular atrophy (SMA): maternal and neonatal outcomes with multi-speciality management.
Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinal muscular atrophy (SMA) is a rare inherited disorder that results in skeletal muscle wasting and weakness with a varying degree of severity. Pregnancy is associated with several changes in respiratory muscle function and respiratory physiology, which can compromise breathing leading to complications during pregnancy and delivery. Pregnant women with SMA are therefore considered to be a high-risk obstetric group. Due to the rare nature of the condition, it is infrequently encountered in pregnancy and this highlights the clinical importance of reporting this current case series. We report, in this retrospective case series, the outcomes of eight pregnancies in six women living with SMA, including, to our knowledge, the first reported successful pregnancy in a woman with SMA type-1, managed in our tertiary multi-professional and multi-speciality centre. All pregnancies, over an 18-year period, resulted in healthy live births between 30 and 39 weeks of gestation, six were pre-term (before 37 weeks gestation) and two were term. Although there were no maternal deaths, four women had a deterioration in respiratory function during the second trimester. All, but one returned to their pre-pregnancy state by three months postpartum. One had an obstetric-related post-partum complication and returned to pre-pregnancy baseline by the first year postpartum. Our case series, of a rare neuromuscular condition in pregnancy, strongly supports that appropriate multi-professional and multi-speciality care for pregnant women living with SMA enhances the outcome for both mother and baby. Indeed, two of our women had the confidence to proceed with a second pregnancy, both of which concluded in good outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.